Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab

"LTD Multiprofile Clinic Consilium Medulla", Tbilisi

Országos Onkológiai Intézet, Budapest

High Technology Hospital MedCenter LTD, Batumi

Montefiore Medical Center, The Bronx

New York Oncology Hematology, P.C., Albany

H.U. V. de las Nieves, Granada

The Harry and Jeanette Weinberg Cancer Institute, Baltimore

Hospital Universitario Lucus Augusti, Lugo

University of North Carolina at Chapel Hill, Chapel Hill

Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda

Woodlands Medical Specialists, Pensacola

Institut Bergonié - Oncologie Médicale et Pédiatrique, Bordeaux

Florida Cancer Specialists - North, St. Petersburg

Florida Cancer Specialists - South, Fort Myers

Tennessee Oncology, PLLC, Nashville

Fundación Instituto Valenciano de Oncología, Valencia

Hospital Politecnic Universitari La Fe, Valencia

Northwest Cancer Specialists, P.C., Tigard

Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy

Hopitaux Universitaires de Strasbourg - Service Oncologie et Hématologie, Strasbourg

Centre Léon Bérard - Département d'oncologie médicale, Lyon

Hôpital Européen Georges Pompidou - Service d'Oncologie Médicale, Paris

Rocky Mountain Cancer Centers, Littleton

Beacon Cancer Center PLLC, Coeur d'Alene

Valkyrie Clinical Trial, Los Angeles

The Oncology Institute of Hope and Innovation, Whittier

National Center of Urology Named after Laur Managadze, Tbilisi

Jasz-Nagykun-Szolnok Megyei Hetenyi Geza Korhaz - Rendeloint, Szolnok

Uzsoki Utcai Kórház, Budapest

Institut Català d'Oncologia-Hospital Universitari Germans Trias i Pujol, Badalona

ALTHAIA, Xarxa Assistencial Universitiria de Manresa, Manresa

Hospital Universitario Vall d´Hebron, Barcelona

Hospital Clinic de Barcelona - Servicio de Oncología Médica, Barcelona

Hospital de la Santa Creu i Sant Pau, Barcelona